<DOC>
	<DOCNO>NCT00941902</DOCNO>
	<brief_summary>Soluble secrete protein express uniquely specific organ whose formation secretion regulate disease state excellent marker disease . This disease diagnose simply measure level secrete protein serum . A soluble form asialoglycoprotein receptor could promise candidate marker case liver fibrosis secondary steatohepatitis exist marker satisfactory . The human asialoglycoprotein receptor ( ASGPR ) express hepatocytes . The H2a alternatively splice variant ASGPR H2 subunit differs H2b variant presence extra pentapeptide . EGHRG , exoplasmic domain next membrane-spanning segment . H2a rapidly cleave a36 kDa fragment , comprise entire ectodomain , secrete . H2a participate membrane bound receptor complex H1 case H2b thus subunit receptor precursor soluble secreted form protein ( sH2a ) . Although H2a type II transmembrane protein , signal peptidase probably responsible cleavage soluble form . The objective research proposal study association level sH2a . serum severity fibrosis steatohepatitis patient undergo bariatric surgery due morbid obesity . The existence sH2a normal human serum constant level . On hand membrane ASGPR ( express exclusively hepatocytes ) profoundly - regulate liver cancer cirrhosis . The investigator analyze level sH2a serum patient steatohepatitis different stage fibrosis compare healthy subject . A possible early down-regulation sH2a fibrosis may prove valuable diagnostic tool .</brief_summary>
	<brief_title>A Potential Novel Marker Liver Fibrosis NASH : Soluble Secreted Form Human Asialoglycoprotein Receptor</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>1 . Signed informed consent . 2 . Patient candidate bariatric surgery . 1 . Liver biopsy last 12 month . 2 . The surgeon consider liver biopsy special dander specific patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>human asialoglycoprotein receptor ( ASGPR )</keyword>
	<keyword>hepatocytes</keyword>
	<keyword>bariatric surgery</keyword>
</DOC>